Valbiotis Management
Management criteria checks 3/4
Valbiotis' CEO is Sebastien Peltier, appointed in Mar 2017, has a tenure of 9.5 years. total yearly compensation is €322.00K, comprised of 55.9% salary and 44.1% bonuses, including company stock and options. directly owns 2.74% of the company’s shares, worth €489.19K. The average tenure of the management team and the board of directors is 7.7 years and 7.5 years respectively.
Key information
Sebastien Peltier
Chief executive officer
€322.0k
Total compensation
| CEO salary percentage | 55.90% |
| CEO tenure | 9.5yrs |
| CEO ownership | 2.7% |
| Management average tenure | 7.7yrs |
| Board average tenure | 7.5yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2025 | €322k | €180k | -€9m |
| Sep 30 2025 | n/a | n/a | -€10m |
| Jun 30 2025 | n/a | n/a | -€11m |
| Mar 31 2025 | n/a | n/a | -€11m |
| Dec 31 2024 | €242k | €180k | -€10m |
| Sep 30 2024 | n/a | n/a | -€9m |
| Jun 30 2024 | n/a | n/a | -€9m |
| Mar 31 2024 | n/a | n/a | -€8m |
| Dec 31 2023 | €301k | €180k | -€7m |
| Sep 30 2023 | n/a | n/a | -€8m |
| Jun 30 2023 | n/a | n/a | -€9m |
| Mar 31 2023 | n/a | n/a | -€11m |
| Dec 31 2022 | €318k | €180k | -€12m |
| Sep 30 2022 | n/a | n/a | -€11m |
| Jun 30 2022 | n/a | n/a | -€10m |
| Mar 31 2022 | n/a | n/a | -€9m |
| Dec 31 2021 | €259k | €180k | -€9m |
Compensation vs Market: Sebastien's total compensation ($USD371.48K) is about average for companies of similar size in the French market ($USD375.11K).
Compensation vs Earnings: Sebastien's compensation has increased whilst the company is unprofitable.
CEO
Sebastien Peltier (48 yo)
Mr. Sebastien Peltier, Ph D., HDR serves as the Chief Executive Officer of Valbiotis SA and is its Co-Founder. Mr. Peltier has been Member of Management Board of Valbiotis SA from March 7, 2017 and is its...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 9.5yrs | €322.00k | 2.74% € 489.2k | |
| CFO & Member of Management Board | 2.2yrs | €195.00k | 0.042% € 7.6k | |
| COO & Member of the Management Board | 5.3yrs | €89.00k | no data | |
| CSO & Member of the Management Board | 8yrs | €259.00k | 0.14% € 25.6k | |
| CMO & Member of the Management Board | 7.7yrs | €167.00k | 0.071% € 12.6k | |
| Member of the Management Board | 1.7yrs | €209.00k | no data | |
| Head of Global Business Development | 7.7yrs | no data | no data |
Experienced Management: ALVAL's management team is seasoned and experienced (7.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Member of Supervisory Board | 7.5yrs | no data | no data | |
| Independent Chairman of Supervisory Board | 9.5yrs | no data | no data | |
| Member of Scientific & Medical Board | no data | no data | no data | |
| Member of Scientific & Medical Board | no data | no data | no data | |
| Member of Scientific & Medical Board | no data | no data | no data | |
| Member of Scientific & Medical Board | no data | no data | no data | |
| Member of Scientific & Medical Board | no data | no data | no data | |
| Independent Member of Supervisory Board | 8.9yrs | no data | no data | |
| Member of Supervisory Board | less than a year | no data | no data | |
| Member of Supervisory Board | less than a year | no data | no data |
Experienced Board: ALVAL's board of directors are considered experienced (7.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/15 18:45 |
| End of Day Share Price | 2026/09/15 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Valbiotis SA is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mohamed Kaabouni | Portzamparc BNP Paribas |
| Corentin Marty | TPICAP Midcap |